Skip to main content
. 2023 May 4;2023(5):CD013798. doi: 10.1002/14651858.CD013798.pub2

9. Long‐term results (approximately 24 months after initiation of treatment) for QoL (all risk groups combined).

Trial time point of measurement
(in months)
Intervention (N analysed) Intervention post mean score (SD) Comparator (N analysed) Comparator post mean score (SD)
Scale: EQ‐5D‐VAS (score range 0‐100; higher scores represent better QoL)
NCT02231749 23.7 NIV+IPI (N = 342) (mean (SD) not reported)
mean change 10.07 (4.35 to 15.80)
SUN (N = 351) (mean (SD) not reported)
mean change 6.40 (‐1.36 to 14.16)
Scale: FACT‐G (score range 0‐108; higher scores represent better QoL)
NCT02231749 23.7 NIV+IPI (N = 352) (mean (SD) not reported)
mean change 4.77 (1.73 to 7.82)
SUN (N = 356) (mean (SD) not reported)
mean change ‐4.32 (‐8.54 to ‐0.11)
Scale: FACIT‐F (score range 0‐52; higher scores represent better QoL)
NCT00720941 23.5 PAZ (N=39) 39.9 (8.33) SUN (N = 36) 37.7 (8.46)

Comparisons including SUN are bold. The scales are listed in no particular order.